Illinois PBM Law to Limit Steering, Other Plan Design Features in 2026 - ogletree.com
Illinois has enacted a law effective in 2026 that limits pharmacy benefit manager (PBM) steering and other plan design features, affecting how pharmacies are included in networks and reimbursed.
Aforeworn detected this change in the Pharmacy & Controlled Substances space on August 11, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Medium urgency. Independent pharmacies, retail chains, compounding pharmacies, and long-term-care pharmacies operating in Illinois or serving Illinois patients. should confirm how it applies to their specific situation before acting. There is a time constraint attached: Effective in 2026; exact date not specified in the excerpt.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Pharmacy & Controlled Substances continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
Starting in 2026, PBMs in Illinois will face new restrictions on steering patients to certain pharmacies and on certain plan design features, potentially altering network participation and reimbursement structures.
Who it affects
Independent pharmacies, retail chains, compounding pharmacies, and long-term-care pharmacies operating in Illinois or serving Illinois patients.
What you must do
Review current PBM contracts and network participation to assess alignment with the new law; monitor for updated PBM policies and adjust contracting strategies accordingly.
Deadline
Effective in 2026; exact date not specified in the excerpt.
Never miss a change like this again
Aforeworn watches Pharmacy & Controlled Substances around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Pharmacy & Controlled Substances
- Changes Coming For Prescribers To The Texas Prescription Drug Monitoring Program - JD Supra
- Schedules of Controlled Substances: Rescheduling of Suvorexant, Lemborexant, and Daridorexant from Schedule IV into Schedule V
- Congress Introduces SAFE Drugs Act of 2025, Expanding FDA Oversight of Compounded GLP-1 Drugs and Telehealth Providers - dykema.com
- Court Rules Feds Need Warrant to Access Drug Prescriptions Database - American Civil Liberties Union
- Wisconsin bill would crack down on predatory practices by pharmacy benefit managers - wpr.org